Predictors at Gout Incidence | HR (95% CI) |
---|---|
Diagnosis year 2009–2010 (vs 1989–1992) | 1.14 (0.95–1.36) |
Age (per 10-yr change) | 1.01 (0.96–1.06) |
Sex, male | 1.16 (0.94–1.42) |
1+ joints affected | 1.23 (0.96–1.59) |
Joint other than first MTP affected | 1.16 (0.98–1.38) |
Starting uric acid–lowering therapy | 0.95 (0.74–1.22) |
Serum uric acid level | 1.13 (1.07–1.19) |
Abnormal serum uric acid (≥ 7 mg/dl for males and ≥ 6 mg/dl for females) | 1.59 (1.16–2.18) |
BMI ≥ 30 kg/m2 | 0.96 (0.81–1.13) |
Diuretic use | 1.17 (0.99–1.38) |
Total cholesterol, per 10 mg/dl change | 1.00 (0.98–1.02) |
Triglycerides, per 10 mg/dl change | 1.00 (0.99–1.01) |
Kidney disease | 1.34 (1.12–1.61) |
Hypertension | 1.07 (0.90–1.27) |
Diabetes mellitus | 1.16 (0.94–1.43) |
Hyperlipidemia | 1.04 (0.88–1.23) |
MTP: metatarsophalangeal; BMI: body mass index.